Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_assertion type Assertion NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_head.
- NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_assertion description "[The IGF1 19 CA repeat polymorphism interacted with hormone replacement therapy (HRT) among NHW post-menopausal women; women who had the 19/19 IGF1 genotype were at reduced risk of breast cancer (OR 0.64, 95% CI 0.47-0.88) if they did not use HRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_provenance.
- NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_assertion evidence source_evidence_literature NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_provenance.
- NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_assertion SIO_000772 17051426 NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_provenance.
- NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_assertion wasDerivedFrom befree-2016 NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_provenance.
- NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_assertion wasGeneratedBy ECO_0000203 NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_provenance.